Heska Corp (HSKA.OQ)
HSKA.OQ on NASDAQ Stock Exchange Capital Market
6.90USD
12:00pm EDT
6.90USD
12:00pm EDT
Price Change (% chg)
$-0.05 (-0.72%)
$-0.05 (-0.72%)
Prev Close
$6.95
$6.95
Open
$6.85
$6.85
Day's High
$6.90
$6.90
Day's Low
$6.85
$6.85
Volume
593
593
Avg. Vol
4,505
4,505
52-wk High
$10.22
$10.22
52-wk Low
$6.60
$6.60
About
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. It operates in two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA)... (more)
Overall
| Beta: | 1.63 |
| Market Cap (Mil.): | $40.05 |
| Shares Outstanding (Mil.): | 5.80 |
| Dividend: | 0.10 |
| Yield (%): | 5.80 |
Financials
| HSKA.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 161.86 | 27.50 | 37.76 |
| EPS (TTM): | 0.04 | -- | -- |
| ROI: | 0.48 | 9.26 | 18.76 |
| ROE: | 0.48 | 12.54 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $29.06 | -0.17 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Merck & Co., Inc. (MRK.N) | $48.20 | +0.03 |
| Bayer AG (BAYGn.DE) | €89.43 | +2.08 |
| Bayer AG (BAYE.F) | -- | -- |
| Sanofi SA (SASY.PA) | €76.85 | -3.32 |
| Eli Lilly & Co. (LLY.N) | $53.29 | +0.18 |
| IDEXX Laboratories, Inc. (IDXX.OQ) | $99.52 | +1.53 |
| Virbac SA (VIRB.PA) | €146.80 | -3.20 |
| Vetoquinol SA (VETO.PA) | €26.68 | -0.14 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: TheStreet.com Ratings
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

